G�떒諛깆쭏 �븣�뙆 12�뿉 �쓽�븳 �븫�꽭�룷�� �삁愿��궡�뵾�꽭�룷�쓽 epigenetic 議곗젅 by �씠�쁽�젙
  
저작자표시-비영리-변경금지 2.0 대한민국 
이용자는 아래의 조건을 따르는 경우에 한하여 자유롭게 
l 이 저작물을 복제, 배포, 전송, 전시, 공연 및 방송할 수 있습니다.  
다음과 같은 조건을 따라야 합니다: 
l 귀하는, 이 저작물의 재이용이나 배포의 경우, 이 저작물에 적용된 이용허락조건
을 명확하게 나타내어야 합니다.  
l 저작권자로부터 별도의 허가를 받으면 이러한 조건들은 적용되지 않습니다.  
저작권법에 따른 이용자의 권리는 위의 내용에 의하여 영향을 받지 않습니다. 
이것은 이용허락규약(Legal Code)을 이해하기 쉽게 요약한 것입니다.  
Disclaimer  
  
  
저작자표시. 귀하는 원저작자를 표시하여야 합니다. 
비영리. 귀하는 이 저작물을 영리 목적으로 이용할 수 없습니다. 
변경금지. 귀하는 이 저작물을 개작, 변형 또는 가공할 수 없습니다. 
Epigenetic regulation by G protein 
alpha12 in human cancer cells and 
vascular endothelial cells
      
HYEONJEONG LEE
Department of Medical Science
The Graduate School, Yonsei University
Epigenetic regulation by G protein 
alpha12 in human cancer cells and 
vascular endothelial cells
Directed by Professor Eun Jig Lee
The Doctoral Dissertation
submitted to the Department of Medical Science,
the Graduate School of Yonsei University
in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy
HYEONJEONG LEE
June 2015
This certifies that the Doctoral 
Dissertation of Hyeon Jeong Lee is 
approved.
이 은 직
Thesis Supervisor: Eun Jig Lee
안 철 우
Thesis Committee Member#1: Chul Woo Ahn
윤 호 근
Thesis Committee Member#2: Ho Geun Yoon
김 형 표
  Thesis Committee Member#3: Hyoung-Pyo Kim
서 미 란
Thesis Committee Member#4: MiRan Seo
The Graduate School 
Yonsei University
June 2015
TABLE OF CONTENTS
Abstract…………………………………………….……………………....1
Part Ⅰ. Up-regulation of XAF1 by Ga12 knock down induces cell 
death in A549 lung cancer cell line …………………...…….…3
1. INTRODUCTION………………………..………..……………....3
2. MATERIALS AND METHODS ……………………..…..….……7
A. Cell culture …………………………………….……..…..…...7
B. Small interfering RNA transfection ………………... …...........7
C. Western blot analysis.………...…………………………... …..7
D. RNA isolation and RT-PCR…………………………….……...8
E.    Immunofluorescence…………………………………….….....9
F.    Immunoprecipitation …………………………………….…....9
G. TUNEL assay ………………………………………...............10
H. Annexin V staining……………………………………….......10
I.    Methylation-specific PCR (MSP) ………………………...….11
J.    Methylated DNA Immunoprecipitation (MeDIP) ….…….......11
K. DNMT Activity Assay ………………………….…..…........12
L.   Statistical analysis……………………………….….……..….12
3. RESULTS …………………………………………….……...........13
A. Expression of XAF1 was regulated by Ga12………….……...13
B.   Restoration of XAF1 by Ga12 down-regulation was appeared
in NSCSCs…...………………………….……...………......…15
C.   DNA methylation of XAF1 controlled by Ga12 in A549 cells
………..…...…………...……………........................................17
D. DNMT1 mediate DNA methylation change by Ga12 knock 
down…………………..……………………………...…..........19
E.    Effect of the up-regulation of XAF1 expression by Ga12
knockdown on XIAP expression and localization…...….…...21
F.    Effect of Ga12 knockdown on apoptosis………........………23
4. DISCUSSION…………………………………………….…..…..26
Part Ⅱ. Up-regulation of p16 by siGa12 inhibits cellular proliferation 
of HepG2 cells ………………………………………….....…..30
1. INTRODUCTION…………………………………………...…...30
2. MATERIALS AND METHODS ……………………..…….....…31
A. Cell culture ……………………………………………..…....31
B. Small interfering RNA transfection………………...…...........31
C. Western blot analysis.………...……………………….....…...31
D. RNA isolation and RT-PCR …………………………...……..32
E.   Immunofluorescence……………………………………........32
F.    Methylation-specific PCR (MSP) ……………………………33
G. Methylated DNA Immunoprecipitation (MeDIP)…….…… ...33
H. DNMT Activity Assay ……………………………………......34
I.    Cell cycle analysis…………………………………….…..…..34
J.    Cell Growth Assay………………………………….……..….35
K. Soft Agar Assay…………………………………….…...…….35
L.   Statistical analysis……………………………….……..……..35
3. RESULTS ……………………………………………..……....…..36
A. Effect of Ga12 knockdown on p16 expression in various
Cancer cell lines……………………………………….........…36
B.   Re-expression of p16 by siGa12 revealed in HepG2 cells…...38
C.   DNA methylation by Ga12 in HepG2 cells .………….............40
D. Down-regulation of Ga12 decreases DNMT1- mediated 
p16 methylation……….……..………………………....…....42
E.    Regulation of Histone modification by Ga12 ……..……..…44
F.    Effect of Ga12 knockdown on HepG2 cells proliferation..…46
4. DISCUSSION………………………………………...…………..49
Part III. Ga12 inhibits serum deprivation induced- apoptosis of 
endothelial cells by miRNA regulation……………….…........52
1. INTRODUCTION…………………….……………….………....52
2. MATERIALS AND METHODS ……….……………………...…54
A. Cell culture ………………………….…...……..…………….54
B.   Small interfering RNA transfection……….……..…..….........54
C.   Western blot analysis.……….………………….……...…..…54
D. TUNEL assay ………………………..…………....….............55
E.    miRNA qRT-PCR detection and quantification…......…..........55
F.    miRNA mimic, inhibitor transfection……………….……......56
G. Statistical analysis…………………………..………..…….....56
3. RESULTS …………………………………….……………..….....57
A. Ga12 siRNA augments serum withdrawal-induced apoptosis
of HUVEC………………………………………………...…..57
B.   Ga12 is related to the regulation of microRNAs expression
……………………………………………….…….….…..…...60
C.   Ga12 siRNA augments apoptosis of HUVECs by suppressing
the expression of miR-155…………………...…...…….....…..62
4. DISCUSSION………………………………………..…….…....…65
Ⅳ. CONCLUSION…………………………………………………..…….68  
REFERENCES…………………………………………………………….69
ABSTRACT(IN KOREAN)………………………………………......…..74
LIST OF FIGURES
Figure 1. Expression level of XAF1 in various cancer cells
and XAF1 expression was controlled by Ga12 ·······14
Figure 2. Ga12 regulates expression level of XAF1 in human
NSCLC cell lines ···········································16
Figure 3. Knock down of Ga12 up-regulates expression of
XAF1 via promoter demethylation·······················18
Figure 4. Ga12 regulates both expression and activity of 
DNMT1·······················································20
Figure 5. Restoration of XAF1 by siGa12 sequestrates XIAP
in nuclear ···················································· 22
Figure 6. Effect of Ga12 knockdown on apoptosis················24
Figure 7. Effect of Ga12 knockdown on p16 expression in 
various cancer cell lines ·····································37
Figure 8. Restoration of p16 expression by siGa12 in HCCs ·····39
Figure 9. Methylation of p16 promoter was controlled by 
Ga12 in HepG2 cells ········································41
Figure 10. DNMT1 mediates epigenetic modification by Ga12
knock down···················································43
Figure 11. Regulation of Histone modification by Ga12···········45
Figure 12. Ga12 promotes hepatoma carcinoma cell proliferation 
and tumorigenicity in HepG2 cell··························47
Figure 13. Effect of Ga12 siRNA on serum deprivation-
induced apoptosis of HUVECs···························58
Figure 14. Ga12 is related to regulation of micro RNAs
expression···················································61
Figure 15. Effect of miR-155 on serum deprivation-induced
Ga12 siRNA-mediated apoptosis in HUVECs ·········63
- 1 -
ABSTRACT
Epigenetic regulation by G protein alpha12 in human cancer cells 
and vascular endothelial cells
Hyeon Jeong Lee
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Eun Jig Lee)
Heterotrimeric guanine nucleotide binding proteins (G proteins) transmit a 
variety of extracellular signals from cell surface G protein-coupled receptors 
(GPCRs) to intracellular effector molecules.
Ga12/13-mediated signals formed networks with other signaling proteins at 
various levels, from cell surface receptors to transcription factors, to regulate 
cellular responses. The G12 subfamily is composed of Ga12 and Ga13.
Accumulating evidence indicates that Ga12/13-mediated signaling pathways 
are involved in a variety of physiological processes, including embryonic 
development, cell growth, cell polarity and migration, angiogenesis, platelet 
activation, immune response, apoptosis, and neuronal responses.
Epigenetic mechanisms denote gene expression variability without coding 
sequence alteration. Epigenetic machinery includes DNA methylation, histone 
modifications and regulation of gene expression posttranscriptionally by small, 
non-coding RNA molecules. Epigenetic modifications play essential roles in the 
regulation of gene expression and are important in mammalian development 
and disease processes.
In this study aim to examine whether Ga12 signaling pathway regulates 
epigenetic modification and to evaluate this change has any physiological 
meaning.
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In Part Ⅰ, we investigated Ga12 action on apoptosis which is mediated by 
epigenetic modification of XAF1 promoter in NSCLCs. Basal XAF1 mRNA 
level was very weakly detected in NSCLCs. However, XAF1 expression was 
restored in A549 cells when blocked Ga12 signal. According to data from 
MSP and MeDIP, XAF1 promoter methylation was reduced by siGa12. In 
our data shown that siGa12 was enhanced demethylation of XAF1 promoter 
and was induced apoptosis.
In Part Ⅱ, we aimed to investigate the effect of Ga12 on cellular 
proliferation and its underlying mechanism in HepG2 human hepatoma cells.
p16 expression was significantly enhanced in HepG2 cells after siGa12
transfection. From MSP, MeDIP and DNMT1 expression data, we can show that 
Ga12 regulates p16 expression by epigenetic modification mechanism, by 
inducing DNMT1 expression and activation. Therefore, Ga12 siRNA inhibits 
the proliferation of HepG2 cells by upregulating p16 expression, suggesting that 
the abnormal proliferation of HepG2 cells might be resulted from Ga12
signaling to suppress p16 expression of HepG2 hepatoma cells.
In part Ⅲ, we aimed to investigate the role of Ga12 in serum withdrawal
-induced apoptosis of HUVECs, and its underlying mechanisms. Ga12 siRNA 
markedly increased the serum deprivation-induced apoptosis of HUVECs. 
Because miR-155 has been reported to regulate apoptosis of HUVECs, we 
examined apoptotic effect of Ga12 on the miR-155 expression. Results 
indicated that Ga12 regulates the apoptosis of vascular endothelial cells by 
regulating miR-155 expression. These results suggest that Ga12 protects 
vascular endothelial cells against vascular injuries causing endothelial 
dysfunction by regulating miR-155 expression. 
From these results, we conclude that Ga12 regulates epigenetic modification 
in cancer cell and vascular endothelial cells. 
---------------------------------------------------------------------------------------------------------
Key words : Ga12, epigenetic modification, cancer, vascular disease, XAF1, p16, 
miRNA
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Epigenetic regulation by G protein alpha12 in human cancer cells 
and vascular endothelial cells
Hyeon Jeong Lee
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Eun Jig Lee)
PartⅠ. Up-regulation of XAF1 by Ga12 knock down induces cell 
death in A549 lung cancer cell line
1. INTRODUCTION
The term epigenetics refers to heritable changes in gene expression that does 
not involve changes to the underlying DNA sequence; a change in phenotype 
without a change in genotype. At least three systems including DNA 
methylation, histone modification and non-coding RNA (ncRNA)-associated 
gene silencing are currently considered to initiate and sustain epigenetic change.
1  
DNA hypomethylation can activate oncogenes and initiate chromosome 
instability, whereas DNA hypermethylation initiates silencing of tumor 
suppressor genes. An accumulation of genetic and epigenetic errors can 
transform a normal cell into an invasive or metastatic tumor cell. Additionally, 
DNA methylation patterns may cause abnormal expression of cancer-associated 
genes. 2 Global histone modification patterns are also found to correlate with 
cancers such as prostate, breast, and pancreatic cancer. Subsequently, epigenetic 
changes can be used as biomarkers for the molecular diagnosis of early cancer.
3,4 Deregulation in any of these histone modifications may shift the balance of 
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gene expression leading to alterations in critical cellular processes such as 
transcription, proliferation, apoptosis, and DNA repair, ultimately resulting in 
cellular transformation and malignant outgrowth. 2,5
Heterotrimeric guanine nucleotide binding proteins (G proteins) transmit a 
variety of extracellular signals from cell surface G protein-coupled receptors 
(GPCRs) to intracellular effector molecules. G proteins consist of two 
functional signaling units, a guanine nucleotide binding a subunit and bg
subunit dimer. Upon receptor activation, the a subunit undergoes a 
conformational change that leads to the exchange of GTP for GDP and the 
dissociation of the a subunit from the bg dimer, allowing the subunits to engage 
their downstream effectors. Because of the array of extracellular signals that 
activate them and their increasingly large number of intracellular targets, G
proteins have been implicated in many physiologic and pathophysiologic 
processes. 6
Ga subunits are classified into four subfamilies, Gs, Gi, Gq and Ga12. Gas 
and Gai are mainly involved in the stimulation and inhibition of adenylyl 
cyclases, respectively, to regulate the intracellular concentration of cAMP. 
PLCb (phospholipase C-b) isozymes are well established effectors for all 
members of the Gq sub family and generate IP3 (inositol 1, 4, 5 triphosphate) 
and DG (diacylglycerol) from PIP2 (phosphatidylino sitol 4, 5 bisphosphate) at 
the plasma membrane. IP3 increases intracellular Ca2+ levels and DG is 
involved in the activation of PKC (protein kinase C). 7,8 In addition to the 
regulation of soluble intracellular second messengers, it has been clearly 
demonstrated that Ga12/13 and Gaq are directly involved in the activation of 
RhoGTPases. The RhoGTPases are members of the RAS superfamily of 
monomeric GTP binding proteins. It has been demonstrated that the activation 
of RhoGTPase results in a variety of cellular responses including gene 
transcription, embryogenesis and rearrangement of the actin cytoskeleton. 7,9
The two members of the G12 family in mammals, Ga12 and Ga13, have 
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received considerable attention in the context of cell proliferation and 
morphology. Ga12/13-mediated signals formed networks with other signaling 
proteins at various levels, from cell surface receptors to transcription factors, to 
regulate cellular responses. Ga12/13 have slow rates of nucleotide exchange 
and GTP hydrolysis, and specifically target RhoGEFs containing an 
amino-terminal RGS homology domain (RH-RhoGEFs), which uniquely 
function both as a GAP and an effector for Ga12/13. 10,11
Ga12-mediated signaling has been shown to stimulate the activity of a 
diverse set of downstream proteins that have not been demonstrated to interact 
directly with Ga12 or Ga13. These include phospholipase D, phospholipase C, 
phospholipase A2, JNK and p38MAPK, and NF-κB. 12,13 Ga12-mediated 
signaling has also been shown to trigger phosphorylation of vasodilator
-stimulated phosphoprotein, as well as phosphorylation of the focal adhesion 
proteins paxillin, focal adhesion kinase, and p130 Crk-associated substrate. 13 In 
addition to the responses described above, Ga12 proteins have been reported to 
promote signaling through GSK-3b, stimulate ERK5, and control Na+-H+ 
exchange. 14 More recently, several groups have begun to examine the biologic 
significance of Ga12-stimulated cell growth and neoplastic transformation in 
human cancers. The earliest of these studies demonstrated that Ga12 expression 
is stronger in cell lines derived from human breast, prostate, and colon cancers 
compared to cell lines derived from nontransformed human tissue. This finding 
suggested that the Ga12 proteins are upregulated during neoplastic 
transformation of these common forms of cancer. 13,14
Ga12 is involved in Rho family GTPase signaling and have been linked to 
several cellular regulatory processes, including cytoskeletal rearrangement and 
oncogenic transformation. 15 Expression of the Ga12 proteins is significantly 
elevated in prostate cancer. Expression of the activated forms of Ga12 in PC3 
and DU145 cell lines induced cell invasion through the activation of the RhoA 
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family of G proteins. JNK activation is required for Ga12-induced invasion of 
breast cancer cells and that JNK is downstream of Rho and ROCK on this 
pathway. 12,16,17
XIAP associated factor 1 (XAF1) antagonizes the anticaspase activity of 
XIAP and may be important in mediating apoptosis resistance in cancer cells. 
The pro-apoptotic effects of XAF1 may be mediated by direct sequestration of 
XIAP from the cytosol to the nucleus, thus antagonizing the inhibition of 
caspases 18. XAF1 could sequester XIAP protein to the nucleus, it was proposed 
that loss of XAF1 in tumor may decrease the functional pool of cytoplasmic 
XIAP, which in turn deregulates the apoptotic process and thus contributes to 
malignant tumor progression, growth suppressive role. 19
Loss of XAF1 expression through promoter methylation has been implicated 
in the process of tumorigenesis in a variety of cancers. XAF1 reduction is 
associated with promoter hypermethylation in human stomach, bladder, kidney, 
and prostate carcinomas. 
G proteins regulate apoptosis in addition to other cellular functions, but the 
roles of specific G protein in apoptosis signaling are not well characterized. 
Herein, we examined whether Ga12 regulates apoptosis in lung cancer cells 
through changed XAF1 promoter epigenetic modification. 
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2. MATERIALS AND METHODS
A. Cell culture
A549, FRO, HepG2, HCT116, MCF7 cells were grown in RPMI1640 
medium containing 10% FBS, 100 units/ml penicillin and 100 mg/ml. TPC-1, 
H1299 cell lines were grown in DMEM medium supplemented with 10% FBS,
100 units/ml penicillin and 100 mg/ml. Cells were cultured in a 5% CO2 
incubator at 37℃.
B. Small interfering RNA transfection
Ga12 was knocked down using ON-Target plus-SMARTpool pooled siRNAs 
(Thermo Scientific Dharmacon, Lafayette, CO, USA) that contains four 
different siRNAs (D-008435-00-0010). A nonspecific control pool was used for 
the negative control (Invitrogen Life Technology, CA, USA). Cells were 
transfected with siRNA using Lipofectamine 2000 reagents according to the 
manufacturer's guidelines. Briefly, 100 pmol of siRNA and Lipofectamine 2000 
were added separately to OPTI MEM medium. After 5 min, the two solutions 
were mixed and incubated for 20 min at room temperature. The mixture was 
added to monolayer of cells seeded in 10cm tissue culture plates. The media 
were replaced with complete cell culture medium after 6 h and whole-cell 
lysates were prepared 48 h later for detection of protein expression.
C. Western blot analysis
The whole cell lysates were prepared with lysis buffer (50 mM Tris-HCl, 150
mM Sodium chloride, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 
pH 7.5, and 2mM EDTA, 1 mM sodium orthovanadate, 0.1 mM 
phenylmethylsulfonyl fluoride, 0.5% NP-40, protease inhibitor cocktail.) The 
protein concentration was determined by the bicinchoninic acid assay (BCA 
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protein assay kit, Pierce) with bovine serum albumin as the standard. Equal 
aliquots of total cell lysates (50 ug) were solubilized in sample buffer and 
electrophoresed on denaturing SDS-polyacrylamide gel (10% and 15% 
separating gel). The proteins were transferred to polyvinylidene difluoride 
membranes. The membranes were blocked with 5% nonfat dry milk in TBS 
containing 0.05% Tween 20 and incubated with primary antibodies overnight at 
4℃ and then with horseradish peroxidase-conjugated secondary antibodies for 
2hr at RT. Antigen-antibody complexes were detected with WEST-SAVE Up
luminol-based ECL reagent (ABfrontier, Seoul, Korea).
D. RNA isolation and RT-PCR
Total RNA from each cell was isolated using Isol-RNA Lysis Reagent
(5-Prime, Gaithersburg, MD, USA) according to the manufacturer's protocol. 
The RNA samples were treated with DNase I, quantified, and 
reverse-transcribed into cDNA using the ReverTra Ace-α First Strand cDNA 
Synthesis kit (Toyobo, Osaka, JAPAN).
RT–PCR was performed using primers specific for XAF1 (sense primer: 
5’-CTTCAGCTCCACAGAGAAGAACTGC-3’, antisense primer: 5’-CACG
ATCATGTTGGACAACTGCTCC-3’) and GAPDH (sense: 5’- CAAGGTCA
TCCATGACAA CT-3’, antisense: 5’- TTCACCACCTTCTTGATGTC -3’). The 
cycling conditions were as follows: initial denaturation at 95℃ for 5min, 
followed 35cycles at 95℃ for 45s, 60℃ for 45s and 72℃ for 45s. Band 
intensities of the amplified DNAs were compared after visualization on an UV 
transilluminator.
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E. Immunofluorescence.
A549 cells were grown on poly-D-lysine coated confocal dishs. Cells were 
transfected with Ga12 siRNA for 48h, washed in PBS, and fixed 10 min with 
4% methanol. Cells were permeabilized 5 min with 0.1% Triton X-100, and 
blocked in 5% donkey serum. Cells were incubated with rabbit anti-XAF1
primary antibody at 1:50 in blocking buffer, followed by donkey 
anti-rabbit-FITC secondary antibody at 1:100. Antibody incubations were 
performed for 1 h at RT. All cells were also stained with DAPI.
F. Immunoprecipitation
Protein extracts were prepared from cells 48 h after Ga12 siRNA transfection
in lysis buffer containing 10% Triton X-100, 10% glycerol, 400 mM NaCl, 10 
mM Tris pH 8.0, 1 mM phenyl methyl sulphonyl fluoride and aprotinin. After 
being sonicated with an ultrasound sonicator, whole lysates were centrifuged at
16,000 g for 10 minutes to remove cell debris. Lysates were pre-cleared with 10 
ml of rabbit pre-immune serum coupled to protein A/G agarose for 2 h, 
followed by low-speed centrifugation. Immunoprecipitations were performed 
using 5 mg of affinity-purified rabbit polyclonal anti- XAF1 antibody for 2 h. 
Protein A/G-agarose was added for 90 min, and antibody complexes were 
collected and washed three times in lysis buffer. Immunoprecipitation samples
were resolved by SDS-PAGE and analyzed by immunoblotting. The protein 
samples were subjected to SDS-PAGE and transferred on to polyvinylidene 
difluoride membranes. The membranes were blocked with 5% nonfat dry milk 
in TBS containing 0.05% Tween 20 and incubated with primary anti-XIAP
antibody and then with horseradish peroxidase-conjugated secondary antibody. 
Antigen-antibody complexes were visualized by the ECL system (ABfrontier, 
Seoul, Korea).
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G. TUNEL assay 
A549 cells were seeded on confocal dish and transfected with Ga12 siRNA . 
After Ga12 siRNA transfection for 48h, apoptosis was determined by terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay 
using a kit methodology (Roche, Nutley, USA). Briefly, cells were washed once 
with PBS and fixed in 4% paraformaldehyde for 1 h at 25℃. Cells were washed 
with PBS and incubated in permeabilization solution (0.1% triton X-100 in 
0.1% sodium citrate) for 2 min on ice. They were then washed twice with PBS 
and treated with TUNEL reaction mixture for 1 h at 37℃ in the dark in a 
humidified atmosphere. Finally, the cells were washed three times with PBS 
ananalyzed under fluorescence microscope (Carl Zeiss, Oberkochen, Germany), 
using an excitation wavelength in the range of 450 - 500 nm and a detection 
wavelength in the range of 515 - 565 nm (green). 
H. Annexin V staining 
Apoptosis was determined by staining cells with Annexin V-fluorescein 
isothiocyanate (FITC, PharMingen, San Diego, CA, USA; Ex/Em =488 nm/519 
nm) and propidium iodide (PI; Sigma-Aldrich;Ex/Em = 488 nm/617 nm). In 
brief, 1x106 cells in 100 mm culture dish were incubated with transfected 
siGa12 for 24 h. Cells were washed twice with cold PBS and then resuspended 
in 500 μl of binding buffer (10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 
mM CaCl2) at a concentration of 1x106 cells/ml. 5 μl of Annexin V-FITC and 
PI (1 μg/ml) were then added to these cells, which were analyzed with a 
FACScan/CellFit system flow cytometer (Becton-Dickinson, San Jose, CA, 
USA).
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I. Methylation-specific PCR (MSP) 
Treatment of DNA with bisulfite converts cytosine residues to uracil, but 
leaves 5-methylcytosine residues unaffected. We used reagents supplied in 
Imprint DNA modification kit (Sigma, St. Louis, MO, USA) for bisulfite 
treatment, according to the one-step modification procedure recommended by 
the manufacturer. Briefly, 10 μl of DNA solution was combined with 110 μl of 
Imprint Bisulfite Modification Reagent, denatured at 99°C for 6 min and 
incubated at 65°C for 90 min. For purification of bisulfite-treated DNA, we 
used the Spin column in Imprint DNA modification kit. The modified DNA was 
then stored at −20°C until use.
For MSP, the modified DNA (100 ng) was amplified with Taq polymerase. 
The methylated or unmethylated XAF1 primer sets were: unmethylated XAF1 
sense, 5'- TTTGGAAAAGGGATGGAGATTTAGATG-3', antisense, 5'- ACAA
ACTTTCAATTAAATTTCA-3'; methylated XAF1 sense, 5'- TTTATTTTATTG
GTAGACGTTACG -3', antisense, 5'-ATAACTCCTAAACTTCCAAAC G-3'.
J. Methylated DNA Immunoprecipitation (MeDIP)
1 mg of DNA extracted from cell lines. 5mC immunoprecipitation was 
carried out using the EpiQuik Methylated DNA Immunoprecipitation (MeDIP) 
Kit (Epigentek Inc, Brooklyn, NY, USA) according to the manufacturer's 
specifications. First, wells were washed once with Wash Buffer (WB; CP1) and 
then incubated at RT for 1 h in the presence of 100 ml of Antibody Buffer (AB; 
CP2) supplemented with 1 ml of 5mC antibody (or 1 ml of Normal Mouse IgG, 
as a negative control). DNA samples, diluted with ChIP Dilution Buffer (CP4), 
were added into the assay wells and incubated at RT for 90 min on an orbital 
shaker. The wells were washed six times with 1 WB, followed by the addition 
of TE Buffer. Afterwards, the DNA Release Buffer containing proteinase K 
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were added to each well and samples were incubated at 65℃for 15 min. Then, 
samples were incubated in Reverse Buffer at 65℃ for 30 min, Binding Buffer 
were subsequently added to the wells, and the released samples, transferred to 
the F-Spin column, were centrifuged at 14 000 g for 20 s. purified DNA was 
eluted in 15 ml of Elution Buffer. PCR was performed using immuno-
precipitated DNA. PCR products were separated on 2% agarose gel and 
visualized by ethidium bromide staining.
K. DNMT Activity Assay
DNMT activity was determined in the nuclear extracts using the EpiQuik
DNA Methyltransferase Activity Assay Kit (Epigentek Inc., Brooklyn, NY, 
USA) following the manufacturer’s protocol. Briefly, DNMT enzymes transfer 
a methyl group to cytosine from Adomet to methylate the DNA substrate, and 
the methylated DNA can be recognized with an anti-5-methylcytosine antibody.
The ratio or amount of methylated DNA, which is proportional to enzyme 
activity, can then be measured using an ELISA-like reaction by reading the
absorbance at 450 nm by the Tecan Infinite M2000 spectrophotometer. The 
DNMT activity was expressed as a percentage of the corresponding siRNA
control.
L. Statistical analysis
Results are expressed mean ± S.D. Statistical analysis are as performed by
student's t-test. Relationships were considered statistically significant when 
p- value was less than 0.05. 
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3. RESULTS
A. Expression of XAF1 was regulated by Ga12
We screened the expression of the XAF1 in various cancer cell lines. To 
measure the endogenous expression level of XAF1, RT-PCR analyses was 
performed on various cancer cell lines. The results indicate that XAF1 express 
in HepG2, MCF7 cells compared with HUVEC normal control cells, and not 
detectable in A549, FRO, TPC-1, and HCT116 cells (Figure 1.A). To 
determine whether Ga12 regulated XAF1 expression level, cancer cells were 
transient transfected with Ga12 siRNA. Knockdown of Ga12 increased the 
basal expression level of XAF1 in A549, HepG2, and MCF7 cells, but not 
changed XAF1 expression in other cell lines. Particularly, Western blot and 
RT-PCR for Ga12 in A549 cells were predominantly re-expressed XAF1 
protein and mRNA level by Ga12 down regulation. (Figure 1.B, C). These 
results demonstrate that Ga12 adjusted XAF1 expression in A549 cells.
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Figure 1. Expression level of XAF1 in various cancer cells and XAF1 
expression was controlled by Ga12. (A) Endogenous XAF1 mRNA level was 
measured by RT-PCR in various cancer cell lines. (B) Effect of Ga12 on XAF1 
expression level. Cancer cells were transient transfected with Ga12 siRNA for 
48h. XAF1 mRNA level detected by RT-PCR (C) Western blot and RT-PCR for 
Ga12 in A549 cells reveal restoration of XAF1 protein and mRNA levels by 
Ga12 siRNA. 
A.
B.
C.
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B. Restoration of XAF1 by Ga12 down-regulation was appeared in 
NSCLCs
To describe the influence of Ga12 in XAF1 expression, we screened the 
expression of the XAF1 in other lung cancer cell lines. XAF1 basal mRNA 
level was very weakly detected in all NSCLC cells compare with normal cell 
line (Figure 2.A). However, XAF1 expression was markedly restored by 
blocking of Ga12 signal in A549 cells and H1299 cells (Figure 2.B). 
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Figure 2. Ga12 regulates expression level of XAF1 in human NSCLC cell 
lines. (A) Total RNA isolated from 2 NSCLC cell lines and HUVEC 
normal control cells. Ga12 and XAF1 mRNA basal level detected by 
RT-PCR (B, C) A549 cells were transfected with Ga12 siRNA for 48h. 
H1299 cells were transfected with p115RGS that inhibit downstream 
signals of Ga12. XAF1 expression level was measured by RT-PCR.
B. C.
A.
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C. DNA methylation of XAF1 controlled by Ga12 in A549 cells
To elucidate whether aberrant DNA methylation is associated with gene 
silencing of XAF1, A549 cell were treated the demethylating agent 
5-Aza-2′deoxycytidine (5-Aza-dC). 5-Aza-dC treated in A549 cells was XAF1 
re-expression that was shown same aspect increased XAF1 by Ga12 siRNA 
transfection (Figure 3.A). To determine whether Ga12 regulate methylation 
of XAF1 promoter region, we used MSP and Methylated DNA 
Immunoprecipitation (MeDIP) after siGa12 transfection. According to data 
from MSP, XAF1 was methylated in A549 cells. However, XAF1 promoter 
methylation was reduced by siGa12. The same effect was obtained when 
cells were treated 5-Aza-dC (Figure 3.B). Moreover, the data from MeDIP 
show that siGa12 lowers the frequency of 5-methylcytosine on the promoters of 
XAF1 (Figure 3.C)   
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Figure 3. Knock down of Ga12 up-regulates expression of XAF1 via promoter 
demethylation. (A) Effects of Ga12 and 5-Aza-dC on promoter methylation and 
expression of XAF1 in A549 cells. A549 cells were transfected with siGa12 
RNA for 48h or treated 5-Aza-dC (10 µΜ) for 5days. XAF1 expression was 
evaluated by RT-PCR. (B) MSP analysis was performed to determine the 
promoter methylation of XAF1. 100 ng of bisulfite modified genomic DNA was 
subjected to PCR amplification of the XAF1 promoter sequences using 
unmethylation specific and methylation specific primer sets, respectively. M; 
methylated, U unmethylated. (C) Methylated DNA immunoprecipitation assay 
was performed to promoter methylation status. Immunoprecipitation of genomic 
DNA from A549 cells with antibody against 5-methylated-cytosine followed by 
RT- PCR analysis of MeDIP. Input as DNA control and IgG as negative control.  
A.
B.
C.
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D. DNMT1 mediate DNA methylation change by Ga12 knock down 
As we confirmed that methylation in XAF1 was influenced by Ga12, we 
tried to find the mediating factors. First of all we checked the DNMT1 
expression which is most common methyltransferase. In both siGa12 and 
5-Aza-dC treatment, DNMT1 expression was decreased (Figure 4.A). In 
addition to complete loss of DNMT1 protein in the whole cell lysates and 
nuclear extracts, DNMT activity was severely reduced upon both siGa12 and 
5-Aza-dC treatment (Figure 4.B). 
From these results, we can show that Ga12 regulates XAF1 expression by 
epigenetic modification mechanism by inducing DNMT1 expression and 
activation. 
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Figure 4. Ga12 regulates both expression and activity of DNMT1. (A) A549
cells were transfected with siGa12 RNA and exposed to 5-Aza-dC for 48h and 
5days, respectively. Expression of DNMT1 and Ga12 were analyzed by 
RT-PCR. Results were representative of three separated experiments. (B) A549
cells were transfected with Ga12 siRNA. DNMT activity was determined in the 
nuclear extracts, and the methylated DNA can be recognized with an anti-5-
methylcytosine antibody. The ratio or amount of methylated DNA, which is
proportional to enzyme activity, can then be measured using an ELISA-like 
reaction by reading the absorbance at 450 nm.
A.
B.
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E. Effect of the up-regulation of XAF1 expression by Ga12 
knockdown on XIAP expression and localization
XAF1 was a nuclear protein to exert its proapoptotic effect by directly 
interacting with XIAP and inducing XIAP sequestration in nuclear inclusion. To 
investigate interaction between XAF1 and XIAP in siGa12 transfected A549 
cells, we used fluorescence confocal microscopy to observe the localization of 
XAF1 and XIAP. XAF1 was not detected and endogenous XIAP was observed 
predominantly in the cytoplasm in control siRNA transfected cells. However, 
restoration of XAF1 expression by siGa12 triggered a edistribution of XIAP 
from the cytosol to the nucleus (Figure 5.A). The possibility of recovering 
XIAP by immunoprecipitation with an anti- XAF1 antibody was investigated. 
Coimmunoprecipitation analysis revealed the XIAP protein was precipitated in 
cellular nucleus and increased in Ga12 knockdown cells (Figure 5.B). As 
shown in these data, siGa12 increased XAF1 interaction with XIAP.   
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Figure 5. Restoration of XAF1 by siGa12 sequestrates XIAP in nuclear. (A) 
A549 cells were transfected with siGa12 for 48h. Confocal microscopy 
observed for the cellular localization of XAF1 with XIAP in siGa12 transfected 
A549 cells. Immunodetection was performed using specific antibodies linked to 
fluorescence performed using specific antibodies linked to fluorescence probes: 
Anti XIAP with cy3 (red) and anti XAF1 with FITC (green). Nuclei were 
stained with DAPI (blue). (B) Nuclear proteins were extracted from siGa12 
transfected A549 cells to evaluate the coimmunoprecipitation of XIAP with 
anti-XAF1 antibodies. input as positive control. 
A.
B.
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F. Effect of Ga12 knockdown on apoptosis 
Next, to determined physiological roles of XAF1 in lung cancer, we 
performed functional studies. TUNEL assays revealed apoptotic DNA 
fragments after siGa12 transfection (Figure 6.A). I tried to investigate whether 
Ga12 enhance cisplatin action, because A549 is a cisplatin resistant cells. As 
shown in westernblot data, Ga12 knock down induced the cleaved caspase3 in 
A549 cells. Moreover, siGa12 transfected cells were increased apoptosis in the 
presence of cisplatin compared with only cisplatin (Figure 6.B). In 
flowcytometry analysis, there was a 3-fold increase in the percentage of 
apoptotic cells with siGa12 transfected cells + cisplatin when compare with 
siCtrl transfected cells+ cisplatin (Figure 6.C). Restoration of functional XAF1 
by siGa12 could be effective in overcoming cisplatin resistance by sensitization 
of tumor cells to cisplatin induced apoptosis.   
- 24 -
Figure 6. Effect of Ga12 knockdown on apoptosis. (A) Microscopic detection 
of apoptotic cells by TUNEL after siGa12 RNA transfection for 48h. (B) 
Casapse3 activation by Ga12 downregulation. Cells were transfected with 
siGa12 and its effect on cisplatin induced caspase3 activation was examined by 
C.
A.
B.
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immunoblotting assay using antibody specific for cleaved caspase3. The 
b-actin control using the same blot indicates equal protein loading. (C) The 
effect of siGa12 on either early or late stage of A549 apoptosis as detected by 
flowcytometry. A549 cells were transfected with Ga12 siRNA for 24h and then 
incubated without (control) or with 20 µM cisplatin. After 24 h, the cells were 
harvested, stained with Annexin V-FITC and PI, and analysed by flowcytometry. 
Diagrams of FITC-Annexin V/PI flowcytometry in a representative experiment 
are presented below the graphs. The lower right quadrants represent the cells in 
the early stage of apoptosis. The upper right quadrants contain the cells in the 
late stage of apoptosis or necrosis.
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4. DISCUSSION
In this study, we characterized the role of Ga12 in the regulation of XAF1 
function and demonstrate that downregulation of Ga12 with Ga12 siRNA 
mediates XAF1 induced apoptosis in A549 lung cancer cells. 
Heterotrimeric G proteins regulate variety of cellular processes including 
proliferation, differentiation, junctional assembly, and apoptosis. The a-subunits 
of heterotrimeric G proteins can be divided into four families based on sequence 
homology: Gs, Gi, Gq, and G12.The last of the four families to be identified, 
the G12 family has been of particular interest to cancer researchers, since its 
members were found to promote the growth and oncogenic transformation of 
murine fibroblasts. 17 These findings led to the hypothesis that GPCRs may 
signal through the Ga12 proteins to promote tumorigenesis and tumor cell 
growth. Many studies have suggested a role for the members of the G12 family 
of heterotrimeric G proteins in oncogenesis and tumor cell growth. The Ga12 
proteins are up-regulated in breast cancer and that Ga12 signaling promotes 
breast cancer metastasis by stimulating breast cancer cell invasion. Signaling by 
Ga12 proteins through the RhoA family of GTPases is a potent stimulator of
prostate cancer cell invasion. 16
In preliminary experiments, we used the Ga12 siRNA transfection system to 
the study on new roles of Ga12. We confirmed that expression of XIAP gene 
was controlled by siGa12 transfection in NSCLCs. XAF1 is one of the XIAP 
interacting partners and induce apoptosis. Therefore, this finding led to the 
hypothesis that Ga12 may adjust apoptosis of cancer cells via modulation of 
XAF1.
XAF1 was first identified as an interacting protein of XIAP. XAF1 
antagonizes the anticaspase activity of XIAP. XAF1 is a nuclear protein that 
directly interacts with endogenous XIAP and results in XIAP sequestration in 
nuclear inclusions. The sequestering of XIAP in nuclear inclusions is 
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compatible with the observed increase in the sensitivity of cancer cell lines to 
apoptotic triggers when XAF1 is overexpressed.18 Consistent with this, we 
observed that restoration of XAF1 expression by Ga12 knockdown reversed
XIAP-mediated protection against apoptosis. Subcellular distribution studies 
revealed that XAF1 resides in the nucleus, and can effect a marked 
relocalization of endogenous XIAP protein from the cytoplasm to the nucleus.
We also could detect the nuclear translocation of XIAP protein in tumor cells 
undergoing apoptosis by XAF1 restoration.
This study also demonstrated the mechanisms by which Ga12 regulates the 
apoptosis of lung cancer cells. XAF1 is a putative tumor suppressor that its
mRNA is present ubiquitously in all normal tissues but is expressed at low or 
undetectable levels in various cancer cell lines. In many cancers, the CpG 
islands of selected genes are aberrantly methylated, resulting in repression of 
transcription of these genes. 19 Recent studies have suggested that loss of XAF1 
expression may occur in different human cancers because of aberrant DNA 
methylation. 20,21 Zou et al found that loss of XAF1 expression is associated 
with tumor progression in human gastric and colon cancers. 21 Lee et al also 
discovered that downregulation of XAF1 expression is correlated with human 
urogenital malignancies.22
In this study, we found that XAF1 expression is upregulated in low 
expression A549 cells following Ga12 siRNA transfection and aberrant 
hypermethylation of the promoter is tightly associated with downregulation of 
XAF1 expression in A549 cells. And we show that XAF1 promoter methylation 
was reduced by siGa12. Thus this suggests that Ga12 regulates XAF1 
expression by epigenetic modification mechanism. DNA methylation, catalyzed 
by DNA methyltransferase, involves the addition of a methyl group to the 
carbon 5’ position of the cytosine ring in the CpG dinucleotide to form 
methylcytosine. We found that the amount of DNMT1 expression and DNMT 
activity have correlation with the expression and methylation status of the 
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XAF1 gene. The eEF2 methylation is preceded by ras-raf-mitogen-activated 
protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK1/2)-
p21Cip/WAF1 activation. eEF2, a key factor involved in protein translational 
elongation is symmetrically arginine-methylated in a reversible manner, being 
regulated by bFGF through MAPK signaling pathway.23 Soberanes, S. et al. 
observed that exposure to PM results in a mitochondrial-oxidant and 
JNK-mediated increase in the transcription and abundance of DNMT1 and 
increased methylation of the p16 promoter in the lung epithelium. Aberrant 
upregulation of DNMT1 could result in early and coordinated hypermethylation 
of key tumor suppressor genes in PM exposed patients, increasing the risk for 
the development of lung cancer. 24 c-Jun NH(2)-terminal kinase (JNK) is a key 
downstream effector of G12 on this pathway. Expression of 
constitutively-active Ga12 or activation of G12 signaling by thrombin leads to 
increased JNK and c-Jun phosphorylation. These observations predict 
mechanism that G12 adjusts methylation of XAF1 promoter through MAPK 
pathway (e.g. ERK1/2 or JNK) mediated DNMT modulation.
Byun et al reported the importance of transcriptional regulation by 7 CpG 
dinucleotides located in the 5’ proximal region from -23 to -234 nucleotides in 
both gastric cancer cell lines and tumor tissues.25 A cluster of methylated CpG 
sites instead of CpG islands located in the promoter area resulted in gene
silencing of XAF1, and CpGs at -2nd, -1st, and +3rd positions are functionally 
more important in its transcriptional regulation.21 While we showed a 
correlation between aberrant methylation of XAF1 and Ga12 regulation and 
lung cancer progression, the exact promoter region could not be confirmed.
Therefore, confirmation of XAF1 promoter methylation site in lung cancer cell 
may be need further study.
Some lung cancer cells are resistant against to cisplatin-induced tumor 
regression, leading to the conjecture that defective response to growth
suppression effect of cisplatin may give the tumors a selective advantage. In this
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context, it could be suspected that lung cancers with XAF1 inactivation might 
be more resistant to cisplatin drug therapy than cancers with normal XAF1 
expression, and restoration of functional XAF1 could be effective in 
overcoming cisplatin resistance by sensitization of tumor cells to cisplatin 
induced apoptosis.
XAF1 induces cell cycle arrest during G2/M phase and mitotic catastrophe, 
and the restoration of XAF1 expression inhibits tumor growth in many types of 
human cancers. 26 However, we could not observe that restoration of XAF1 
expression inhibit tumor cell growth.
Several regulatory pathways of XAF1 expression have been reported. In 
addition to hypermethylation of XAF1 promoter, Wang, Jide et al reported that 
heat shock factor 1 negatively while interferon regulatory factor-1 and STAT1 
positively modulated XAF1 transcription.27,28 Inhibition of ERK1/2 stimulated 
XAF1 expression through indirect transcription regulation. Furthermore, XAF1 
was an effector in ERK inhibition-induced cell apoptosis.29 The 
over-expression of XAF1 led to activation of wild-type p53 via 
post-translational modification in cells with or without DNA damage, which 
resulting in p53 nuclear accumulation and its increased transcriptional activity 
and enhancing p53-dependent apoptosis.30 However, we could not observation 
that Ga12–mediated mechanism for regulation of XAF1 expression and 
methylation. Therefore, other mechanisms of transcriptional regulation of the 
XAF1 gene may be present and need further research.
In conclusion, XAF1 undergoes epigenetic silencing in a considerable 
proportion of lung cancer cell lines by aberrant CpG sites hypermethylation of 
the gene promoter. In our data shown that siGa12 was enhanced demethylation 
of XAF1 promoter and was induced apoptosis. Therefore, our data presented 
here demonstrate that Ga12 was caused cancer cell progression and 
maintenance by controlling the methylation of XAF1.
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Part Ⅱ. Up-regulation of p16 by siGa12 inhibits cellular 
proliferation of HepG2 cells
1. INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most common human 
malignancies worldwide, and is closely associated with infection of HBV and 
HCV and contamination of aflatoxin B1. Although the molecular mechanisms 
of hepatocarcinogenesis remain poorly understood, an increasing number of 
genetic abnormalities have been recognized.31
Cyclin-dependent kinase inhibitor 2A, (CDKN2A, p16Ink4A) also known as
multiple tumor suppressor 1 (MTS-1), is a tumor suppressor protein, that in 
humans is encoded by the CDKN2A gene. P16 plays an important role in 
regulating the cell cycle, and mutations in p16 increase the risk of developing a 
variety of cancers.32
Inactivation of p16 by aberrant methylation of CpG islands is a frequent 
event in carcinomas and precancerous lesions of various organs, including the 
stomach. Gastric cancers with higher numbers of methylated genes have more 
distinct DNA methylation profiles than the originally defined CIMP-positive 
GCs. DNA methylation of tumor-related genes accumulates in conjunction with 
tumor progression. HepG2 cells treated with 5-Aza-cdR, showed demethylation 
of the p16 gene. The p16 mRNA and protein were all increased dramatically, 
cell cycle was arrested in G1, apoptotic rate increased and implanted tumor 
grew more slowly.33,34
Ga12 is reported to be involved in tumor cell invasion and progression. 
However, the precise mechanisms by which Ga12 regulates proliferation of 
cancer cells are poorly understood. Thus, we aimed to investigate the effect of 
Ga12 on cellular proliferation and its underlying mechanism in HepG2 human 
hepatoma cells.
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2. MATERIALS AND METHODS
A. Cell culture
A549, FRO, HepG2, HCT116, MCF7 cells were grown in RPMI1640 
medium containing 10% FBS, 100 units/ml penicillin and 100 mg/ml. TPC-1, 
PLC/PRF5 cell lines were grown in DMEM medium supplemented with 10% 
FBS, 100 units/ml penicillin and 100 mg/ml. Cells were cultured in a 5% CO2 
incubator at 37℃.
B. Small interfering RNA transfection
Ga12 was knocked down using ON-Target plus-SMARTpool pooled siRNAs. 
A nonspecific control pool was used for the negative control. Cells were 
transfected with siRNA using Lipofectamine 2000 reagents according to the 
manufacturer's guidelines. Briefly, 100 pmol of siRNA and Lipofectamine 2000 
were added separately to OPTI MEM medium. After 5 min, the two solutions 
were mixed and incubated for 20 min at room temperature. The mixture was 
added to monolayer of cells seeded in 10 cm tissue culture plates. The media 
were added with complete cell culture medium after 6 h and whole-cell lysates 
were prepared 48 h later for detection of protein expression.
C. Western blot analysis
The whole cell lysates were prepared with lysis buffer (50 mM Tris-HCl, 150
mM Sodium chloride, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 
pH 7.5, and 2 mM EDTA, 1 mM sodium orthovanadate, 0.1 mM phenylmethyl
sulfonyl fluoride, 0.5% NP-40, protease inhibitor cocktail.) The protein 
concentration was determined by the bicinchoninic acid with bovine serum 
albumin as the standard. Equal aliquots of total cell lysates (50 ug) were 
solubilized in sample buffer and electrophoresed on denaturing SDS-
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polyacrylamide gel (10% and 15% separating gel). The proteins were 
transferred to polyvinylidene difluoride membranes. The membranes were 
blocked with 5% nonfat dry milk in TBS containing 0.05% Tween 20 and 
incubated with primary antibodies overnight at 4℃ and then with horseradish 
peroxidase-conjugated secondary antibodies for 2h at RT. Antigen-antibody 
complexes were detected with WEST-SAVE Up luminol-based ECL reagent.
D. RNA isolation and RT-PCR
Total RNA from each cell was isolated using Isol-RNA Lysis Reagent
according to the manufacturer's protocol. The RNA samples were treated with 
DNase I, quantified, and reverse-transcribed into cDNA using the ReverTra 
Ace-α First Strand cDNA Synthesis kit.
RT–PCR was performed using primers specific for p16 (sense primer: 5’-
GGAAATTGGAAACTGGAAGC -3’, antisense primer: 5’- CTGCCCATCAT
CATGACCTG-3’) and GAPDH (sense: 5’- CAAGGTCATCCATGACAACT
-3’, antisense: 5’- TTCACCACCTTCTTGATGTC -3’). The cycling conditions 
were as follows: initial denaturation at 95℃ for 5min, followed 35cycles at 
95℃ for 45s, 60℃ for 45s and 72℃ for 45s. Band intensities of the amplified 
DNAs were compared after visualization on an UV transilluminator.
E. Immunofluorescence.
HepG2 cells were grown on poly-D-lysine coated confocal dishs. Cells were 
transfected with Ga12 siRNA for 48h, washed in PBS, and fixed 10 min with 
4% methanol. Cells were permeabilized 5 min with 0.1% Triton X-100, and 
blocked in 5% donkey serum. Cells were incubated with rabbit anti-p16 primary 
antibody at 1:50 in blocking buffer, followed by donkey anti-rabbit-FITC 
secondary antibody at 1:100. Antibody incubations were performed for 1 h at 
RT. All cells were also stained with PI.
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F. Methylation-specific PCR (MSP) 
Treatment of DNA with bisulfite converts cytosine residues to uracil, but 
leaves 5-methylcytosine residues unaffected. We used reagents supplied in 
Imprint DNA modification kit (Sigma, St. Louis, MO, USA) for bisulfite 
treatment, according to the one-step modification procedure recommended by 
the manufacturer. Briefly, 10 μl of DNA solution (100 ng) was combined with 
110 μl of Imprint Bisulfite Modification Reagent, denatured at 99°C for 6 min 
and incubated at 65°C for 90 min. For purification of bisulfite-treated DNA, we 
used the Spin column in Imprint DNA modification kit. The modified DNA was 
then stored at −20°C until use. For MSP, the modified DNA was amplified with 
Taq polymerase. The methylated or unmethylated p16 primer sets were: 
unmethylated p16 sense, 5'- TTTGAGGGATAGGGTTGGAG -3', antisense, 5'-
CTCCCCTTTTTCCAAAAAATCA -3'; methylated p16 sense, 5'-TTGAGGGA
TAGGGTCGGAG-3', antisense, 5'- CCCTTTTTCCGAAAAA TCGAAA -3'. 
G. Methylated DNA Immunoprecipitation (MeDIP)
1 mg of DNA extracted from cell lines. 5mC immunoprecipitation was 
carried out using the EpiQuik Methylated DNA Immunoprecipitation Kit 
according to the manufacturer's specifications. First, wells were washed once 
with Wash Buffer (WB; CP1) and then incubated at RT for 60 min in the 
presence of 100 ml of Antibody Buffer (AB; CP2) supplemented with 1 ml of 
5mC antibody (or 1 ml of Normal Mouse IgG, as a negative control). DNA 
samples, diluted with ChIP Dilution Buffer (CP4), were added into the assay 
wells and incubated at RT for 90 min on an orbital shaker. The wells were 
washed six times with 1 WB, followed by the addition of TE Buffer. Afterwards, 
the DNA Release Buffer containing proteinase K were added to each well and 
samples were incubated at 65℃ for 15 min. Then, samples were incubated in 
Reverse Buffer at 65℃ for 30 min, Binding Buffer were subsequently added to 
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the wells, and the released samples, transferred to the F-Spin column, were 
centrifuged at 14 000 g for 20 s. Purified DNA was eluted in 15 ml of Elution 
Buffer. PCR was performed using immuno- precipitated DNA. PCR products 
were separated on 2% agarose gel and visualized by ethidium bromide staining.
H. DNMT Activity Assay
DNMT activity was determined in the nuclear extracts using the EpiQuik
DNA Methyltransferase Activity Assay Kit (Epigentek Inc., Brooklyn, NY, 
USA) following the manufacturer’s protocol. Briefly, DNMT enzymes transfer 
a methyl group to cytosine from Adomet to methylate the DNA substrate, and 
the methylated DNA can be recognized with an anti-5-methylcytosine antibody.
The ratio or amount of methylated DNA, which is proportional to enzyme 
activity, can then be measured using an ELISA-like reaction by reading the
absorbance at 450 nm by the Tecan Infinite M2000 spectrophotometer. The 
DNMT activity was expressed as a percentage of the corresponding siRNA
control.
I. Cell cycle analysis
The DNA contents of cell were measured by the PI (Sigma, St Louis, MO, 
USA) staining method. Cells (1 X 106) were harvested by trypsinization and 
fixed with 70% ethanol for at least 2 h at -20℃. Fixed cells were rinsed twice 
with PBS, and re-suspended in PBS containing 50 µg/ml RNase A (Sigma, St 
Louis, MO, USA), then incubated in 37℃ for 30 min. PI was added to the cells 
suspension and incubated in the dark for 20 min. Stained cells were analyzed by 
a FACScan flow cytometry.
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J. Cell Growth Assay
Cell growth was determined by cell count. A total of 1 × 104 cells were plated 
in a 6cm plate in complete medium. The following day, cells were transfected 
with Ga12 siRNA . Cell numbers were counted using a hemocytometer for 
3days at 24h intervals. 
K. Soft Agar Assay
1.5 × 104 HepG2 cells, expressing sictrl or siGa12, were mixed with 0.35% 
soft agar and plated on top of a 0.5% bottom agar in a 6-well plate. Cells were 
incubated at 37°C for 2 weeks to allow colony formation. Each cell line was 
plated in triplicate. Three random low-power view fields were chosen, and the 
total number of colonies was counted.
L. Statistical analysis
Results are expressed average ± S.D. Statistical analysis are as performed by
student's t-test. Relationships were considered statistically significant when p-
value was less than 0.05.
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3. RESULTS
A. Effect of Ga12 knockdown on p16 expression in various cancer cell 
lines 
We screened the expression of the p16 gene in various cancer cell lines. 
p16 basal mRNA level was low detected in HepG2, A549, MCF7 cell 
lines compare with other cell lines. To determine whether Ga12 regulated 
p16 expression, cancer cells were transiently transfected with Ga12 
siRNA. However, down-regulation of Ga12 was restored p16 expression 
in HepG2 cells.
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Figure7. Effect of Ga12 knockdown on p16 expression in various cancer cell 
lines. Cancer cells were transient transfected with Ga12 siRNA for 48h. p16
mRNA level detected by RT-PCR.
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B. Re-expression of p16 by siGa12 revealed in HepG2 cells
We screened the expression of the p16 in 2 hepatoma cancer cell lines. p16 
basal mRNA level was very weakly detected in HepG2 cells and PLC/PRF5 cell 
lines (Figure 8.A). p16 expression was significantly enhanced in HepG2 cells 
after siGa12 transfection (Figure 8.B). We confirmed increased p16 expression 
level when blocked Ga12 signal from immunofluorescence study, western blot, 
and RT-PCR in HepG2 cells (Figure 8.C). Therefore all experiments were 
proceeding with HepG2 cells.  
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Figure 8. Restoration of p16 expression by siGa12 in HCCs. (A) Total RNA 
isolated from 2 HCCs and HUVEC normal control cells. Ga12 and p16 mRNA 
basal level detected by RT-PCR (B) HepG2 and PLC/PRF5 cells were 
transfected with Ga12 siRNA for 48h. p16 mRNA expression levels were 
measured by RT-PCR (C) Immunofluorscence, western blot and RT-PCR for 
Ga12 in HepG2 cells reveal restoration of p16 protein and mRNA levels by 
Ga12 siRNA. 
A. B.
C.
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C. DNA methylation by Ga12 in HepG2 cells 
HepG2 cells were treated with 5-Aza-dC or transfected siGa12. 5-Aza-dC 
treated cells induced p16 expression and we obtained similar result by siGa12 
(Figure 9.A). P16 is also frequently inactivated in several cancers via DNA 
methylation. Therefore, we examined whether Ga12 induces p16 promoter 
demethylation. Methylation of the p16 promoter CpG island was assessed by 
MeDIP analysis and MSP on genomic DNA isolated from HepG2 cells.
According to data from MSP, down regulation of Ga12 induced demethylation 
of p16, suggesting that expression of p16 is up-regulation by siGa12 via 
promoter demethylation. The same effect was obtained when cells were treated 
5'-Aza-dC (Figure 9.B). MeDIP assay enabled the purification of enriched 
methylated-DNA by direct immunoprecipitation of the 5′-methylcytosine 
modification related to the CpG sites of the p16 promoter. As shown in here, 
siGa12 decreased 5’-methylcytosine on the promoters of p16 (Figure 9.C).
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Figure 9. Methylation of p16 promoter was controlled by Ga12 in HepG2 cells. 
(A) Effects of Ga12 and 5-Aza-dC on promoter methylation and expression of 
p16 in HepG2 cells. HepG2 cells were transfected with siGa12 RNA for 48h or 
treated 5-Aza-dC (10 µΜ) for 5days. P16 expression was evaluated by RT-PCR.
(B) Methylation of p16 promoter analyzed by MSP. MSP analysis of p16 
promoter compared between siCtrl and siGa12 transfected cells (left). P16
methylation in response to exposure to 5-Aza-dC for 5 days (right). U; 
unmethylated, M; methylated DNA. (C) MeDIP assay was performed to 
promoter methylation status. Immunoprecipitation of genomic DNA from 
HepG2 cells with antibody against 5-Cm followed by RT-PCR analysis of 
MeDIP. Input as DNA control and IgG as negative control.
A.
B.
C.
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D. Down-regulation of Ga12 decreases DNMT1-mediated p16
methylation
We next aimed to gain insights into the mechanisms that underlie 
hypermethylation in HepG2 cells. A crucial step in DNA methylation involves 
DNA methyltransferases that catalyze methylation of CpG dinucleotides in 
genomic DNA. To gain insights into the possible involvement of DNMTs, we 
performed RT-PCR on total RNA samples isolated from siGa12 transfected 
HepG2 cells. DNMT1 mRNA was decreased by Ga12 knockdown. The same 
effect was obtained when cells were treated 5'-Aza-dC (Figure 10.A). In 
addition, the DNMT activity in the nuclear protein extract of siGa12 cells 
decreased compared with sictrl (Figure 10.B), similar to the mRNA and protein 
pattern of DNMT1 by 5'-Aza-dC. From these results, we can show that Ga12 
regulates p16 expression by epigenetic modification mechanism by inducing 
DNMT1 expression and activation. 
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Figure 10. DNMT1 mediates epigenetic modification by Ga12 knock down. 
(A) HepG2 cells were transfected with DNMT1 siRNA for 48h or treated 
5-Aza-dC for 5days. DNMT1 and Ga12 mRNA levels were examined in 
G12-knocked down cells by RT–PCR. (B) Quantification of enzyme activity of 
DNMT1. HepG2 cells were transfected with siGa12 RNA. DNMT activity was 
determined in the nuclear extracts, and the methylated DNA can be recognized 
with an anti-5-methylcytosine antibody. The ratio or amount of methylated 
DNA, which is proportional to enzyme activity, can then be measured using an 
ELISA-like reaction by reading the absorbance at 450 nm.
A.
B.
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E. Regulation of Histone modification by Ga12 
To investigate the histone modification by siGa12, we performed Modified 
Histone peptide array. Histone peptide array is experiment for the assessment of 
change in various histone modifications, such as methylation, acetylation, and 
phosphorylation modification. We obtained outstanding result that siGa12 
increased Histone H3K27 acetylation. This result indicated that Ga12 alter 
chromatin structure by modifying histone tails.
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Figure 11. Regulation of histone modification by Ga12. Protein extracts were 
prepared from cells 48 h after Ga12 siRNA transfection on the Modified 
Histone Peptide Array. P16 primary antibody was used at a 1:2000 dilution for 
overnight at 4℃. Anti-rabbit HRP secondary antibody was used at a 1:2500 
dilution, followed by ECL detection. Active motif’s Array Analysis Software 
was used to analysis spot intensity.
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F. Effect of Ga12 knock down on HepG2 cells proliferation
Next, to determined physiological roles of p16 in liver cancer, we performed 
functional studies. Flow cytometry was performed to observe the effects of 
Ga12 down regulation on cell cycle progression. The proportion of cells in the 
G0/G1 phase was significantly higher in the siGa12 transfected cells compared 
to the proportion of cells in the sictrl cells (Figure 12.A). And we were obtained 
result from cell counting assay that cell number was decreased in Ga12 
knockdown (Figure 12.B). The levels of cell cycle regulatory proteins, such as 
phospho-Rb, E2F and CDK4, were also determined after siGa12 transfection. 
Cell cycle marker proteins were reduced by siGa12 (Figure 12.C). And we were 
obtained result from cell counting assay that cell number was decreased in 
Ga12 knockdown cells. We next examined the effect of Ga12 depletion in liver 
cancer cells on in vitro tumorigenicity using the soft agar colony formation 
assay. Consistent with the proliferation assays, siGa12 cells approximately 
decreased two fold in colony formation numbers. Colony size was reduced in 
Ga12 knockdown cells (Figure 12.D).
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Figure 12. Ga12 promotes hepatoma carcinoma cell proliferation and 
tumorigenicity in HepG2 cells. (A) Cell cycle analysis of Ga12 knockdown 
HepG2 cell by flowcytometry. (B) Cell growth was determined by cell count
assay. HepG2 cells were transfected with Ga12 siRNA. Cell numbers were 
counted using a hemocytometer for 3 days at 24h intervals. (C) Expression of 
cell cycle regulatory proteins E2F, Cdk4 and phospho-Rb in Ga12 knockdown 
cells. Western blots were performed on lysates from siGa12 cells. Comparable 
density of b-actin levels confirms equal loading of total protein. (D) Analysis of 
in vitro tumorigenicity by soft agar assay. HepG2 cells transfected with siGa12 
C.
A. B.
D.
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were seeded in soft agar and maintained for 2 weeks. Colonies were stained 
with crystal violet. Results are representative of at least three independent 
experiments performed in triplicates. Data are expressed as average ± SD 
*p<0.05;**p<0.01.
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4. DISCUSSION
The G12 class includes Gα12 and Gα13 and is ubiquitously expressed in 
mammalian tissues and cells. The last of the four families to be identified, the 
G12 family has been of particular interest to cancer researchers, since its 
members were found to promote the growth and oncogenic transformation of 
murine fibroblasts. Many studies have suggested a role for the members of the 
Gα12 family of heterotrimeric G proteins in oncogenesis and tumor cell growth.
35,36
In breast and prostate cancer cells, previous studies showed a role of Gα12 
and of Gα13 in invasiveness, but not in tumor cell proliferation.16,17 In contrast, 
Grzelinski M et al. reported that in SCLC cells, the downregulation of either 
Gα12 or Gα13 leads to a clear inhibition of proliferation in vitro as well as in 
vivo.37 Our observations indicate that in hepatoma cells, the downregulation of 
Gα12 leads to a clear inhibition of proliferation in vitro and the 
anchorage-independent colony formation. This finding further supports the 
concept that intact Gα12 signaling is a prerequisite for tumor growth in
hepatoma cancer cells. Moreover, Gα12 siRNA restored the expression of 
p16Ink4 known to be silenced in many cancer cells and arrested the cell cycle 
progression of HepG2 cells.
Currently, p16 is considered a tumor suppressor protein because of its 
physiological role and downregulated expression in a large number of tumors.
Inactivation of p16 by aberrant methylation of CpG islands is a frequent event 
in carcinomas and precancerous lesions of various organs.
Precancerous conditions with aberrant DNA methylation appear to generate
HCCs rapidly. Liu, L. H. et al HepG2 cells treated with 5-Aza-dC, showed 
demethylation of the p16 gene. The p16 mRNA and protein were all increased 
dramatically, cell cycle was arrested in G1, apoptototic rate increased and 
implanted tumor grew more slowly.38 We obtained similar result by siGα12. We 
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show that p16 hypermethylation is associated with HCC cell line and 
downregulation of Gα12 induces p16 promoter demethylation. According to 
data from MSP and MeDIP, we suggest that Gα12 expression is correlation with 
hepatocarcinogenesis through aberrant p16 hypermethylation.
Increased DNMT1 mRNA expression in a number of human cancers has been 
reported. Moreover, Sun et al. found that DNA methyltransferase mRNA levels 
were significantly higher in HCC and HCC cell lines. We confirmed that 
DNMT1 was increased in HepG2 cell, and DNMT1 mRNA was decreased by 
Gα12 knockdown. In addition, the DNMT activity in the nuclear protein extract 
of siGα12 cells decreased. From these results, we can show that Gα12 regulates 
p16 expression by epigenetic modification mechanism by inhibiting the 
activities and expression of DNMT. Sarkar et al reported that HDACi inhibited 
cell cycle progression, and reversed promoter methylation and silencing of three 
tumor suppressor genes: RARB2, p16 and p21. HDACi repressed MAP kinase I 
(ERK) activation and down-regulated DNMT1 levels. Recent studies suggest 
that DNA methylation in colon cancer cells and in NIH 3T3 cells may be 
regulated in some circumstances by ERK (MAP kinase1) activity.39 c-JUN is 
also involved in protecting the promoter region of the tumor suppressor 
p16(INK4a), which is consistently methylated over time in c-JUN deficient 
cells.40 The association of JNK1 with the epigenetic alternations, mainly the 
elevation of H3K4me3, H3K9me3, and the expression of EZH2 that is involved 
in both histone and DNA methylation indicates a pivotal role of JNK on the 
development of the human HCC.41 Mitsui, H. indicated that important roles of 
both Ras/MAPK and Ras/Rac/JNK cascades in activated Gα12-induced G1/S 
cell cycle progression.42 Ga12 stimulates cell proliferation and neoplastic 
transformation of NIH3T3 cells by attenuating p38MAPK-associated apoptotic 
responses, while activating the mitogenic responses through the stimulation of 
ERK- and JNK-mediated signaling pathway. These observations expected that 
Ga12 is controlling the activity and expression of DNMT through the 
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stimulation of ERK- and JNK-mediated signaling pathway and this is expected 
to affect the methylation of p16 promoter.
p16 is a protein involved in regulation of the cell cycle. The p16-cyclin 
D1-CDK4-Rb pathway regulates cell cycle transition from the G1 to the S 
phase; point mutations and/or epigenetic modifications in this pathway are 
observed in almost all human cancers. Recent investigations have elucidated 
that G1 to S phase progression requires activation of E2F family transcription 
factors, a process dependent on cyclin dependent kinase-mediated phosphor
rylation and inactivation of pRb family proteins. It is also known that S phase 
entry is associated with transcriptional activation of the cyclin A gene.43 The 
activated transcription factor up-regulates p16 expression. p16 forms a complex 
with Cdk4, leading to the redistribution of p21 and p27 from Cdk4 to Cdk2 and 
then revealed hypophosphorylation of pRb. The hypophosphorylated pRb 
eventually causes cell cycle arrest at G1.44 From figure 6 data, the proportion of 
cells in the G0/G1 phase was significantly higher in the siGα12 transfected cells 
compared to the proportion of cells in the sicontrol cells. The levels of cell cycle 
regulatory proteins, such as phospho-Rb, E2F and CDK4, were also determined 
after siGα12 transfection. Cell cycle marker proteins were reduced by siGα12.
And we were obtained result from cell counting assay that cell number was 
decreased in Gα12 knockdown. Therefore, reactivated p16 by Gα12 knockdown 
may affect the growth of the HCC cell line.
In conclusion, Gα12 siRNA inhibits the proliferation of HepG2 cells by 
upregulating p16 expression, suggesting that the abnormal proliferation of 
HepG2 cells might be resulted from Gα12 signaling to suppress p16 expression 
of HepG2 hepatoma cells. And this study finds, for the first time, which Gα12 
protein regulate cellular signaling pathway via epigenetic modification of target 
gene promoter. 
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Part Ⅲ. Galpha12 inhibits serum deprivation induced-apoptosis of 
endothelial cells by miRNA regulation
1. INTRODUCTION
Vascular complications remain a leading cause of morbidity and mortality in 
subjects with diabetes, and experimental evidence suggests that progression of 
diabetes is associated with profound endothelial dysfunction. The endothelial 
cells play a major role in securing body homeostasis. Under pathological 
conditions, endothelial dysfunction is a driving force in the initiation and 
development of atherosclerosis. Apoptosis is one of the central mechanisms 
leading to endothelial dysfunction and results in inflammatory cell infiltration, 
lipid transport and neointima formation.42 These alterations induce 
atherosclerotic lesion rupture and later clinical complications. Therefore, 
inhibiting ECs apoptosis is a promising novel therapeutic option against
atherosclerosis in diabetes.45
MicroRNAs (miRNAs) are a family of highly conserved, small non-coding 
RNAs that posttranscriptionally repress gene expression via degradation or 
translational inhibition of their target mRNAs.46 There is mounting evidence 
suggesting that miRNAs are involved in nearly all physiological and 
pathological processes. Early studies have revealed a significant role of 
miRNAs in ECs inflammation, migration, senescence, proliferation, and 
apoptosis 47. miR-155 represents a typical multifunctional miRNA. miR-155 is 
involved in numerous biological processes including haematopoiesis, 
inflammation, immunity, cancer, and cardiovascular diseases. miR-155 was 
increased expression of heme oxygenase 1, a stress-inducible enzyme that 
exerts anti-inflammatory effects in the endothelium, and plays a protective role 
in cardiovascular diseases, including atherosclerosis. In HUVECs, miR-155 
targeted the 3′ UTR of eNOS. miR-155 overexpression decreased whereas 
miR-155 inhibition increased eNOS expression and NO production in ECs.48
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And miR-155 is upregulated by unidirectional shear stress and targets the 
angiotensin-II type-1 receptor and Ets-1, which reduces the proinﬂammatory 
activity of angiotensin II on ECs.47 Ga12 is reported to be involved in cell 
proliferation, transformation, tight junction assembly and cell migration. 
However, the mechanism by which Ga12 regulates apoptosis of vascular 
endothelial cells is poorly understood. . Thus, we aimed to investigate the role 
of Ga12 in serum withdrawal-induced apoptosis of HUVECs and its underlying 
mechanisms.
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2. MATERIALS AND METHODS
A. Cell culture
Human umbilical vein endothelial cells (HUVECs) (Invitrogen Life 
Technology, CA, USA) were grown in endothelial cell growth medium-2 
supplemented with 2% fetal bovine serum (FBS), 0.04% hydrocortisone, 0.4% 
human epidermal growth factor (hEGF)-B, 0.1% vascular endothelial growth 
factor (VEGF), 0.1% R3-insulin like growth factor (IGF)-1, 0.1% ascorbic acid, 
0.1% hFGF, 0.1% GA-1000, and 0.1% heparin (Lonza, Basel, Switzerland). 
Cells were used between passages 4 and 9 in this study. Cells were cultured in a 
5% CO2 incubator at 37℃.
B. Small interfering RNA transfection
Ga12 was knocked down using ON-Target plus-SMARTpool pooled siRNAs. 
A nonspecific control pool was used for the negative control. Cells were 
transfected with siRNA using Lipofectamine 2000 reagents according to the 
manufacturer's guidelines. Briefly, 100 pmol of siRNA and Lipofectamine 2000 
were added separately to OPTI MEM medium. After 5 min, the two solutions 
were mixed and incubated for 20 min at room temperature. The mixture was 
added to monolayer of cells seeded in 10cm tissue culture plates. The media 
were replaced with complete cell culture medium after 6 h and whole-cell 
lysates were prepared 48 h later for detection of protein expression.
C. Western blot analysis
The whole cell lysates were prepared with lysis buffer (50mM Tris-HCl, 
150mM Sodium chloride, 1% Triton X-100, 1% sodium deoxycholate, 0.1% 
SDS, pH 7.5, and 2mM EDTA, 1 mM sodium orthovanadate, 0.1 mM 
phenylmethylsulfonyl fluoride, 0.5% NP-40, protease inhibitor cocktail.) The 
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protein concentration was determined by the bicinchoninic acid assay (BCA 
protein assay kit, Pierce) with bovine serum albumin as the standard. Equal 
aliquots of total cell lysates (40ug) were solubilized in sample buffer and 
electrophoresed on denaturing SDS-polyacrylamide gel (10% and 15% 
separating gel). The proteins were transferred to polyvinylidene difluoride 
membranes. The membranes were blocked with 5% nonfat dry milk in TBS 
containing 0.05% Tween 20 and incubated with primary antibodies overnight at 
4℃ and then with horseradish peroxidase-conjugated secondary antibodies for 
2hr at RT. Antigen-antibody complexes were detected with WEST-SAVE Up
luminol-based ECL reagent.
D. TUNEL assay 
HUVEC cells were seeded on confocal dish and transfected with Ga12 
siRNA. After Ga12 siRNA transfection for 48h, apoptosis was determined by 
terminal TUNEL assay using a kit methodology. Briefly, cells were washed 
once with PBS and fixed in 4% paraformaldehyde for 1 h at 25℃. Cells were 
washed with PBS and incubated in permeabilization solution (0.1% triton 
X-100 in 0.1% sodium citrate) for 2 min on ice. They were then washed twice 
with PBS and treated with TUNEL reaction mixture for 60 min at 37℃ in the 
dark in a humidified atmosphere. Finally, the cells were washed three times with 
PBS ananalyzed under fluorescence microscope, using an excitation wavelength 
in the range of 450 - 500 nm and a detection wavelength in the range of 515 -
565 nm (green). 
E. miRNA qRT-PCR detection and quantification
miRNAs were isolated using the mirVana kit and protocol (Ambion, Austin 
Texas, USA). miRNAs were reverse transcribed into cDNAs with a TaqMan 
MicroRNA reverse transcription kit using microRNA-specific primers (Applied 
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Biosystems, Foster City, CA, USA). Briefly, for reverse transcription reactions, 
30 ng miRNA was used in each reaction and mixed with the RT primer. RT 
reaction was carried out at 16◦C for 30 minutes, 42◦C for 30 minutes, and 85◦C 
for 5 minutes. The quantitation of miRNA levels was performed by real-time 
PCR (StepOnePlus; Applied Biosystems, Foster City, CA, USA) using TaqMan 
gene expression assays and TaqMan MicroRNA assays, respectively. The 
ampliﬁcation steps consisted of denaturation at 95◦C, followed by 40 cycles of 
denaturation at 95◦C for 15 s and then annealing at 60◦C for 1 min. All reactions, 
including controls were performed in triplicate. Relative expression of miRNAs 
was analyzed using 2-ΔΔCt method and was normalized by RNU6B expression 
for all samples.
F. miRNA mimic, inhibitor transfection
Cells were transfected with miR-155 mimic and inhibitor by Lipofectamine
2000 according to the manufacturer's protocol. After transfection, cells were 
used in subsequent assays. The level of transfected miR present in HUVECs 
was determined by quantitative real-time -PCR. Transfection of HUVEC was 
performed with stability-enhanced mature miR-155 mimics (miR-155, sense: 
5'-CUCCUACAUAUUAGCAUUAACA-3'; antisense: 5'-UGUUAAUGCUAA
UAUGUAGGAG-3') and the negative control miR (miR-NC, sense: 5'-CCUCG
UGCCGUUCCAUCAGGUAG-3'; antisense: 5'-CUACCUGAUGGAACGGA
CGAGG-3’). Both miR-155 mimics and miR-NC were double-stranded RNA 
oligonucleotides, while miR-155 inhibitors were single-stranded RNA oligon-
ucleotides conjugated with 2' - O -methoxyethyl phoshorothioate (Genolution, 
Seoul, Korea).
G. Statistical analysis
Results are expressed average ± S.D. Statistical analysis are as performed by
student's t-test. Relationships were considered statistically significant when 
p- value was less than 0.05.
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3. RESULTS
A. Ga12 siRNA augments serum withdrawal-induced apoptosis of 
HUVECs
To examine the effects of serum withdrawal on apoptosis of HUVECs, 
HUVECs were deprived from serum for indicated time and assessed for 
apoptosis by Western blotting using antibody against cleaved caspase-3 and by 
TUNEL assay to label apoptotic cells that were viewed under fluorescent 
microscopy. Serum withdrawal induced the apoptosis in time-dependent manner 
and 3h after serum free condition HUVECs were undergoing and proceeding 
apoptosis until 24 h after serum withdrawal (Figure 13.A & B). To investigate 
the role of Ga12 in serum withdrawal-induced apoptosis, HUVECs were 
transfected with Ga12 siRNA to knock down expression of endogenous Ga12, 
and then serum-deprived for 6 h to induce apoptosis. The downregulation of 
Ga12 expression was confirmed at the levels of both mRNA and protein by 
RT-PCR and Western blotting, respectively. As shown in Figure 13C & D, 
Ga12 siRNA markedly increased the serum withdrawal-induced apoptosis of 
HUVECs up to 367% compared to control siRNA-transfected cells in the level 
of cleaved caspase-3, which was confirmed by TUNEL assay. The knockdown 
of Ga12 expression also augmented the serum withdrawal-induced p38 
activation that has been known to mediate the apoptosis of numerous cells 
including endothelial cells. These results show that serum-deprivation induced 
the apoptosis of HUVECs, which was augmented when Ga12 expression was 
knockdown in HUVECs, suggesting that Ga12 might protect vascular 
endothelial cells from endothelial damages such as apoptosis. 
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A.
B.
C.
D.
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Figure 13. Effect of Ga12 siRNA on serum deprivation-induced apoptosis of
HUVECs. (A) HUVECs were cultured in serum-free EBM or 2% fetal bovine
serum-containing EGM as a control. After the indicated time points, these cells
were analyzed by immunoblot using an antibody against cleaved caspase-3.(B) 
Microscopic detection of apoptotic cells by TUNEL assay at 0, 3, 6, 12, or 24h,
respectively, after serum deprivation. (C) HUVEC cell transfected with Ga12
siRNA. After 48h, these cells were deprived serum for 6 h, and then harvest and
lysised for immunoblot analysis against cleaved-caspase3. (D) Microscopic 
detection of apoptotic cells by TUNEL assay after siGa12 RNA transfection for 
48h and then serum-deprived for 6 h to induce apoptosis.
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B. Ga12 is related to the regulation of microRNAs expression
To investigate how Ga12 regulate serum withdrawal-induced apoptosis, we
examined whether Ga12 is related to the regulation of miRNAs expression. 
HUVECs were transfected with Ga12 siRNA, and these cells were assessed for 
the expression of miRNAs, miR-17-3p, miR-31, miR-155 and miR-191 that 
have been reported to be involved in the regulation of endothelial damages 
including inflammation and apoptosis. Ga12 siRNA reduced the expression of 
miR-17-3p, miR-31and miR-191 and remarkably suppressed the miR-155 
expression that has been known to regulate apoptosis of endothelial cells.
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Figure 14. Ga12 is related to the regulation of miRNAs expression. HUVEC
cell transfected with G12 siRNA for 48 h. Relative expression levels of
miR-17-3p, -31, -155, -191 and -338 were analyzed using qRT-PCR. Data are
expressed as average ±SD, ∗p<0.05, ∗∗p<0.01, ∗∗∗ p<0.005 compared to
control group.
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C. Ga12 siRNA augments apoptosis of HUVECs by suppressing the 
expression of miR-155 
To examine the relationship between miR-155 and apoptosis, HUVECs were 
cultured in serum free conditions for 6 h, and then analyzed for expression of 
miR-155, which showed that serum withdrawal significantly suppressed the 
expression of miR-155 by 2 fold (Figure 15.A). To confirm the effects of 
miR-155 on apoptosis of HUVECs, HUVECs were transfected with miR-155 
mimic or miR-155 inhibitor, which were confirmed by analyzing the elevated or 
diminished level of miR-155 compared to control-transfected cells, respectively 
(Figure 15.B). The overexpression of miR-155 by miR-155 mimic protected 
HUVECs against serum withdrawal-induced apoptosis and the inhibition of 
miR-155 expression by miR-155 inhibitor enhanced the apoptosis of HUVECs, 
showing that miR-155 is involved in the regulation of apoptosis of HUVECs 
(Figure 15.C & -D). To examine the role of miR-155 in the regulation of Ga12
siRNA-mediated apoptosis, HUVECs were cotransfected with Ga12 siRNA and 
miR-155 mimic, which showed that miR-155 mimic significantly abolished the 
serum withdrawal-induced, Ga12 siRNA-mediated apoptosis and p38 
phosphorylation of HUVECs (Figure 15. E), indicating that Ga12 regulates the 
apoptosis of vascular endothelial cells by regulating the expression of miR-155.
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B.
C.
D.
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Figure 15. Effect of miR-155 on serum deprivation-induced Ga12 siRNA-
mediated apoptosis in HUVECs. (A)Effect of serum starvation on miR-155
miRNA expression. (B, C and D) Cleaved caspase-3 expression in HUVECs
after serum deprivation, miR-155 mimics or miR-155 inhibitor transfection.
(C&D) Effect of Ga12 on miR-155 expression under condition of serum
withdrawal. HUVECs were transfected with miR-155 mimic/inhibitor. After
24h, these cells were incubated serum starved condition for 6h. And then
harvested and lysed for immunoblot analysis against cleaved caspase-3 (E)
Relevance of Ga12 and miR-155 on serum deprivation–induced apoptosis
through activation of caspase-3 and phosphorylation of p38 MAPK. HUVECs
were cotransfected with Ga12 siRNA and miR-155 mimic for 48 h, and then
incubated in serum deprived condition for 6 h. After serum starvation, HUVECs
were harvest and lysised for immunoblot analysis against cleaved caspase-3 and 
phospho-p38 MAPK.
E.
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4. DISCUSSION
In this study, we investigated the role of Ga12 in the regulation apoptosis of 
vascular endothelial cells and its underlying mechanisms, and we found that 
Ga12 protects HUVECs against serum withdrawal-induced apoptosis by 
inhibiting the suppression of miR-155 expression. This finding is supported by 
the results that Ga12 siRNA increased the serum withdrawal-induced apoptosis 
of HUVECs. Additionally, Ga12 siRNA markedly suppressed the expression of 
miR-155 and the restoration of miR-155 by transfection of miR-155 mimic 
abolished the enhanced apoptosis mediated by Ga12 siRNA, indicating that 
Ga12 could inhibit the apoptosis of HUVECs by retaining the expression of 
miR-155 against cell death signal in vascular endothelial cells. 
G proteins, as a signal transducer, have known to be involved in the 
modulation of cellular responses, including proliferation, differentiation, 
migration and apoptosis. Several studies have shown that Ga12 is involved in 
the regulation of proliferation and migration. Ga12 has found to mediate the 
lysophosphatidic acid-induced proliferation of ovarian cancer cells and to 
simulate the expression of genes promoting cell growth in NIH3T3 cells.49,50
Also, overexpression of constitutively active mutant of Ga12 promoted cell 
invasion of breast and prostate cancer cells16,17 and migration of vascular 
smooth muscle cells (VSMCs) by inducing CYR61 expression.51 Ga12 has also 
reported to exert pro-apoptotic effect in epithelial cells. Overexpression of 
constitutively active mutant of Ga12 stimulated the apoptosis of Madin-Darby 
canine kidney cells through JNK activation and also induced apoptosis of 
COS-7 cells by MAP kinase pathway including apoptosis-signal regulating 
kinase 1 (ASK1) and MAP kinase kinase 1 (MEKK1).52,53 On the other hand, 
we showed that the blockade of endogenous Ga12 expression augmented the 
serum withdrawal-induced apoptosis of HUVECs, which indicated that Ga12 
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inhibits the apoptosis of HUVECs and protects them against cellular stress 
evoking endothelial dysfunctions. Thus it is suggested that the role of Ga12 in 
modulation of apoptosis might be dependent on cell type specificity. Vascular 
endothelial cells (ECs) are one of cells that composed blood vessel, which form 
the lining of inner surface of blood vessel. Injury or damage of ECs by 
inflammatory cytokines, oxidative stress, modified lipoproteins and apoptosis 
has been known to initiate the pathogenesis of vascular diseases such as 
atherosclerosis. Apoptosis of ECs has been regarded as an initial step to develop 
atherosclerosis and found in atherosclerotic plaque and also reported to be 
responsible for the formation of coronary thrombotic atherosclerotic plaque. 
Thus apoptosis of ECs could represent the ECs damage causing endothelial 
dysfunction and it is important to regulate the apoptosis of ECs to prevent and 
inhibit the pathogenesis of atherosclerosis. Thus we revealed the role of Ga12 
in modulation of apoptosis of vascular endothelial cells and suggested that 
Ga12 might play a crucial role in vascular system by regulating damage of ECs. 
This study also demonstrated the mechanisms by which Ga12 regulates the 
apoptosis of vascular endothelial cells. Serum-withdrawal resulted in the 
apoptosis with the repression of miR-155 and Ga12 siRNA remarkably 
suppressed miR-155 expression, which makes HUVECs more susceptible to 
apoptosis induced by serum deprivation. Using miR-155 mimic, we showed that 
the elevation of miR-155 expression inhibited the serum deprivation-induced 
apoptosis of HUVECs and furthermore abrogated the enhanced apoptosis that 
was resulted from blockade of Ga12 expression, indicating that the repression 
of miR-155 might be responsible for increased susceptibility to apoptosis of 
HUVECs. Taken together, our study supports the roles of Ga12 and miR-155 in 
protecting vascular endothelial cells from apoptotic cell death. The role of 
miR-155 has been found to be involved in the development of cancer and the 
pathogenesis of cardiovascular disease including atherosclerosis. miR-155
stimulated cellular proliferation and migration, and inhibited apoptosis of renal 
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cancer cells, indicating that miR-155 contributes to the oncogenesis of tumor 
cells.54 However, the role of miR-155 in the pathogenesis of atherosclerosis has 
been in conflict. Silencing of miR-155 resulted in the enhanced inflammation 
and lipid uptake in macrophages, indicating that miR-155 is anti-atherogenic 
and other study showed that miR-155 exerts pro-atherogenic effects by 
repressing Bcl6 in macrophages.55,56 Whereas, miR-155 is enriched in ECs and 
the effects of miR-155 have been thought to be anti-atherogenic in ECs, 
supported by finding that miR-155 inhibited angiotensin II (Ang II)-induced 
inflammation, migration and apoptosis of HUVECs by targeting Ang II type 1 
receptor (ATR1).57-59 In agreement with that, we found that overexpression of 
miR-155 inhibited serum withdrawal-induced apoptosis of HUVECs and 
prevented the enhanced apoptosis mediated by Ga12 knockdown, indicating 
that miR-155 acts downstream of Ga12 playing a protective role against 
apoptotic cell death. Although Ga12 siRNA markedly reduced the expression of 
miR-155, Ga12 siRNA alone did not induce the detectable apoptosis. Moreover, 
only the inhibition of miR-155 expression also could not induce apoptosis. 
miR-155 inhibitor induced the apoptosis when HUVECs were exposed to 
apoptotic stimulus, indicating that only the repression of miR-155 is not 
sufficient to induce apoptosis and makes HUVECs more susceptible to 
apoptosis, which resulted in the enhanced apoptosis compared to HUVECs that 
retain the expression of miR-155. 
From these results, we conclude that Ga12 protects HUVECs against serum 
withdrawal-induced apoptosis by regulating the expression of miR-155, 
suggesting that endothelial apoptosis can be modulated by Ga12 protein 
signaling through regulation of miRNAs and the novel strategies to protect 
endothelial cells from endothelial dysfunctions by regulating Ga12 protein 
signaling. 
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Ⅳ. CONCLUSION
In part Ⅰ, XAF1 undergoes epigenetic silencing in a considerable proportion 
of lung cancer cell lines by aberrant CpG site hypermethylation of the gene 
promoter. In our data shown that siGα12 was enhanced demethylation of XAF1 
promoter and was induced apoptosis. Therefore, our data presented here 
demonstrate that Gα12 was caused cancer cell progression and maintenance by 
controlling the methylation of XAF1. 
Next, Gα12 siRNA inhibits the proliferation of HepG2 cells by upregulating 
p16 expression, suggesting that the abnormal proliferation of HepG2 cells might 
be resulted from Gα12 signaling to suppress p16 expression of HepG2 
hepatoma cells. 
Finally, Ga12 protects HUVECs against serum withdrawal-induced 
apoptosis by regulating the expression of miR-155. We suggest that novel 
strategies to protect endothelial cells from endothelial dysfunctions by 
regulating Ga12 protein signaling.
These results indicate that Gα12 regulates epigenetic modification in cancer 
and vascular cells.  
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ABSTRACT (IN KOREAN)
G단백질 알파 12에 의한 암세포와 혈관내피세포의
epigenetic 조절
< 지도교수 이은직 >
연세대학교 대학원 의과학과
이현정
G 단백질(Guanine nucleotide binding protein)은 세포의 외부에서 들어
오는 신호를 변화시켜 세포 내로 전달시켜주는 단백질 family 중의 하
나이다. G 단백질은 metabolic enzyme과 ion channel, transporter 등을 조
절한다. 또한 세포내의 전사 조절과 cell motility, contractility, 그리고
secretion 등을 조절하여 embryonic development, learning, memory 그리고
homeostasis 등을 변화시킨다. G12 family는 Ga12와 Ga13의 2개의 멤버
로 구성되고 이들은 세포의 증식과 분화 그리고 세포의 사멸에 관련
되어 있을 뿐만 아니라 세포 형태에도 영향을 준다. 또한 Ga12가 활
성화되면 DNA 합성, 세포 증식과 악성으로의 변성 등이 촉진된다.
Epigenetic 변형은 DNA의 염기서열이 변화하지 않는 상태에서 세포
가 분열되는 동안 DNA 또는 크로마틴의 변형을 통하여 유전자의 발
현 양상이 다음 세대로 그대로 전달되는 현상을 말하며, 여기에는
methylation, histone modification, non-coding RNA, genomic imprinting 등이
속한다. 유전자의 promoter 에서 일어나는 methylation은 유전자의 발현
을 억제하는 기능을 한다. Histone modification은 다양한 chromatin 
remodeling에 의해서 유전자의 발현 조절, 세포 사멸 조절, DNA 복제
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및 repair 그리고 염색체의 응축 및 분열 등에 관여한다. miRNA는
target mRNA에 결합하여 해당 mRNA를 파괴하거나 translation을 억제
하여 유전자 발현을 억제시키는 작용을 한다. 따라서 epigenetic
modification이 정상적으로 이루어지지 않으면 암과 같은 질병들이 유
발된다.
본 연구에서는 Ga12 단백질의 신호 전달이 epigenetic 변형을 조절
하는지 살펴보고, 이러한 epigenetic 변형에 의한 생리학적 의미를 관
찰하고자 하였다.
Part Ⅰ에서는 폐암세포주에서 Ga12가 세포의 apoptosis에 영향을
주는지 살펴보고, 이런 작용이 XAF1 프로모터 부분의 epigenetic 변형
을 조절함으로써 일어나는 것인지 관찰하고자 하였다. 폐암세포주에
서는 XAF1 mRNA가 거의 발현이 되지 않았다. 그러나 A549 세포주에
Ga12의 신호를 차단하였더니 XAF1의 발현이 회복되는 것을 확인할
수 있었다. 또한 MSP와 MeDIP 실험을 통해서 siGa12 에 의해 XAF1 
프로모터의 메틸화가 감소되는 것을 확인하였다. 이러한 실험을 통해
siGa12에 의해서 XAF1 프로모터의 탈메틸화가 증가되고, 이로 인해
세포의 apoptosis 가 유도되는 것을 확인할 수 있었다.
Part Ⅱ 에서는 Ga12가 간암세포주인 HepG2 세포주의 세포증식에
영향을 주는지 살펴보고 그것이 일어나는 기전을 알아보고자 하였다. 
HepG2 세포주에서 거의 발현이 되지 않았던 p16의 발현이 Ga12의
knockdown에 의해 발현이 확연하게 증가되는 것을 확인하였다. MSP와
MeDIP 그리고 DNMT1의 발현을 보는 실험을 통해, Ga12가 p16 프로
모터 부분의 메틸화를 조절함으로써 p16의 발현을 조절하고, 이러한
작용이 DNMT1을 통해서 일어나는 현상임을 알 수 있었다. 이러한 결
과를 통해서 HepG2에서 Ga12 신호가 p16의 발현을 억제함으로써
HepG2 세포의 비정상적이 증식을 일으키는 것을 확인하였다. 
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Part Ⅲ 에서는 혈관내피세포인 HUVECs 에서 무혈청에 의해 유도된
apoptosis 에 Ga12가 미치는 영향을 살펴보고 그것이 어떠한 기전을
통해서 일어나는지 연구를 진행하였다. Ga12가 downregulation이 되면
HUVECs의 apoptosis가 증가되는 것을 확인할 수 있었다. miRNA 중에
miR-155가 HUVECs 의 apoptosis를 유도한다고 알려져 있었기 때문에
Ga12가 miR-155의 발현에 영향을 주는지 관찰하였다. 그 결과 siGa12
가 miR-155의 발현을 억제함으로써 혈관내피세포의 apoptosis를 유도
하는 것을 확인하였다. 이러한 결과들로 보아 Ga12가 miR-155 발현의
조절을 통해서 내피세포 기능장애의 원인이 되는 혈관 injuries로부터
혈관내피세포를 보호한다는 결과를 얻을 수 있었다.
이러한 실험 결과들을 통해서 Ga12가 암세포와 혈관내피세포에서
epigenetic 변형을 조절함으로써 다양한 생리학적 작용을 일으킨다는
결론을 얻을 수 있었고, 이로 인해 Ga12의 새로운 신호전달 기전을
제시하고자 한다.
--------------------------------------------------------------------------------------------------------
핵심되는 말 : Ga12, epigenetic 변형, 암, 혈관질환, XAF1, p16, miRNA
